Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilei Ding

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Ebiomedicine|February 13, 2016
Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated CytotoxicityJonathan Richard, Maxime Veillette, Shilei Ding, et al.
Mbio|March 22, 2018
Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity ResponsesJonathan Richard, Jérémie Prévost, Amy E Baxter, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2022
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infectionJamie Guenthoer, Michelle Lilly, Tyler N Starr, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infectionJamie Guenthoer, Michelle Lilly, Tyler N Starr, et al.
Biorxiv : the Preprint Server for Biology|March 2, 2022
VE607 Stabilizes SARS-CoV-2 Spike In the "RBD-up" Conformation and Inhibits Viral EntryShilei Ding, Shang Yu Gong, Jonathan Grover, et al.
Cell Reports|January 14, 2023
Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicityAnnemarie Laumaea, Lorie Marchitto, Shilei Ding, et al.
Nature Communications|June 20, 2018
A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challengeNavid Madani, Amy M Princiotto, Linh Mach, et al.
Journal of Virology|March 24, 2017
BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular CytotoxicityJonathan Richard, Jérémie Prévost, Benjamin von Bredow, et al.
Nature Communications|July 20, 2023
Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetrySusan A Leonhardt, Michael D Purdy, Jonathan R Grover, et al.
Cell Reports|February 17, 2021
Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2Romain Gasser, Marc Cloutier, Jérémie Prévost, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Ebiomedicine|February 13, 2016
Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated CytotoxicityJonathan Richard, Maxime Veillette, Shilei Ding, et al.
Mbio|March 22, 2018
Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity ResponsesJonathan Richard, Jérémie Prévost, Amy E Baxter, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2022
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infectionJamie Guenthoer, Michelle Lilly, Tyler N Starr, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infectionJamie Guenthoer, Michelle Lilly, Tyler N Starr, et al.
Biorxiv : the Preprint Server for Biology|March 2, 2022
VE607 Stabilizes SARS-CoV-2 Spike In the "RBD-up" Conformation and Inhibits Viral EntryShilei Ding, Shang Yu Gong, Jonathan Grover, et al.
Cell Reports|January 14, 2023
Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicityAnnemarie Laumaea, Lorie Marchitto, Shilei Ding, et al.
Nature Communications|June 20, 2018
A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challengeNavid Madani, Amy M Princiotto, Linh Mach, et al.
Journal of Virology|March 24, 2017
BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular CytotoxicityJonathan Richard, Jérémie Prévost, Benjamin von Bredow, et al.
Nature Communications|July 20, 2023
Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetrySusan A Leonhardt, Michael D Purdy, Jonathan R Grover, et al.
Cell Reports|February 17, 2021
Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2Romain Gasser, Marc Cloutier, Jérémie Prévost, et al.
Pageof 12